Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports

Our Views
Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports
Magazine
Store

About Swarajya

Swarajya is a publication by Kovai Media Private Limited.

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Participate

Contact Us
Write for us
Style Guide
Jobs

Stay Connected

Dr Krishna Ella

Celebrating The Achievers Amidst Us Who Put India First

Aashish Chandorkar

The cover of Savitha Rao’s book Putting #IndiaFirst — India Positive Citizen Perspectives

Lost 10 Years Of Life In Past 18 Months Due To Stress And Excitement Of Developing Covaxin: Dr Krishna Ella

Bharat Biotech chairman and managing director Dr Krishna Ella

Bharat Biotech Chairman Dr Krishna Ella Slams Biased Media Coverage And Domestic Politics Around Covaxin: "It Really Hurts"

Bharat Biotech chairman and managing director Dr Krishna Ella

Bharat Biotech To Supply 3.5 Crore Covaxin Doses In September And 5 Crore In October; 10 Crore Monthly Supply Likely Only In 2022

COVAXIN, India’s first indigenous vaccine against Coronavirus. (Swarajya Magazine)

Karnataka: Bharat Biotech’s New Plant At Kolar To Produce Five Crore Covaxin Doses Per Month From August

Bharat Biotech’s COVAXIN

Phase 1 Trials Of Bharat Biotech's Nasal Vaccine For Covid-19 Now Underway: MD Dr Krishna Ella

Bharat Biotech (Pic Via Wikipedia)

Get Swarajya in your inbox.